Navigation Links
Majority of B.C. women take prescription drugs during pregnancy: UBC study
Date:12/15/2011

Almost two-thirds of women in British Columbia filled at least one prescription at some point in their pregnancy, including drugs with potential risks, according to a new study by University of British Columbia researchers.

The study, published today in the journal Clinical Therapeutics (www.clinicaltherapeutics.com), is the first of its kind in Canada. Researchers analyzed population-based outpatient prescription claims data for patterns of prescription drug use during pregnancy in B.C. from 2001 to 2006.

The researchers found that 63.5 per cent of pregnant women in B.C. filled at least one prescription. One in thirteen or 7.8 per cent filled a prescription for a medicine known to be risky in pregnancy most often for select medicines for anxiety, insomnia and depression. Drugs that are strictly contraindicated pregnancy, however, were filled in less than 0.5% of pregnancies.

"Although much remains to be understood about the appropriateness of medicine use that actually occurs among pregnant women in B.C., one encouraging finding from our study is that existing use of medicines with known risks declines dramatically when women become pregnant," says co-author Steve Morgan, an associate professor in the School of Population and Public Health (SPPH) and Associate Director of the Centre for Health Services and Policy Research (CHSPR).

On average, pregnant women filled 2.6 different types of drugs, while 15 per cent used five or more prescription medications during their pregnancy. Prescriptions most frequently filled during pregnancy were for antibiotics (30.5 per cent), respiratory drugs (25.7 per cent), dermatologics (13.4 per cent), and drugs that act on the nervous system (12.8 per cent).

Other study findings include:

  • The use of medicines in pregnancy slightly increased over time, going from 63 per cent of women in 2001 to 66 per cent in 2006.
  • Women aged 20 years or younger were most likely to take prescription drugs during pregnancy (69 per cent) while the lowest rate occurred among those aged 30 to 35 years (62 per cent).
  • Prescription medication use was also high in the first three months immediately following delivery, a period when women may be breastfeeding, with 61.3 per cent of women filling prescriptions.

"Since pregnant women are normally excluded from clinical trials of new drugs and post-market study is limited, there is little evidence on the risks and benefits of many of the most commonly used drugs in pregnancy," says lead author Jamie Daw, a researcher at CHSPR, part of SPPH. "Given the prevalence of prescription drug use, more research is needed to help pregnant women and their physicians make informed decisions."


'/>"/>
Contact: Katherine Came
katherine.came@ubc.ca
604-822-5030
University of British Columbia
Source:Eurekalert

Related medicine news :

1. Majority of Americans Give Quality of Health Care a C, D or F
2. Majority of U.S. Adults Had Troubled Childhoods: CDC
3. Detroits urban farms could provide a majority of produce for local residents
4. Majority of community facilities performing breast MRI exams meet ACRIN and EUSOBI technical requirements
5. Majority of Ontarians suffering from rheumatoid arthritis not receiving needed speciality care
6. Majority of young victims of unintentional shootings shot by another youth
7. New Poll Finds Majority of Americans Are Unaware of Issues Facing Iraq/Afghanistan Veterans and Troops
8. R-Biopharm Group Purchases a Majority Ownership in Trilogy Lab, Expanding US Operations
9. For Vast Majority, Driving and Cell Phones Dont Mix
10. New iVillage Study Reveals That Majority of Women 18-34 Go Online First With Health Questions - Before Turning to Their Doctor or Other Family Members
11. Pew Report Finds Majority of States Fail to Ensure Proper Dental Health & Access to Care for Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... 23, 2017 , ... PureLife Dental is pleased to announce that California Dental ... As part of the amalgam separator endorsement, all CDA members may purchase an ECO ... the retail value. This partnership between PureLife and CDA is especially timely as it ...
(Date:6/23/2017)... CA (PRWEB) , ... June 23, 2017 , ... Ulster ... 26th June, 2017 from 9 am to 3 pm to present to graduate students ... program is an original curriculum project led by The Health Improvement Service of ...
(Date:6/23/2017)... ... June 23, 2017 , ... All-Star Insurance, a family managed agency that offers ... Texas, is announcing the launch of a new charity drive to benefit women in ... United States reveal that an estimated 252, 710 new cases of invasive or high ...
(Date:6/22/2017)... ... 2017 , ... Branches, Inc. has been partnering with The Miami Foundation for ... its programs focused on providing opportunity to low-income families and breaking the cycle of ... of $15,000 to support its , Climb to College & Career initiative which focuses ...
(Date:6/22/2017)... ... June 22, 2017 , ... Groove Ring is excited ... about their high performance silicon wedding bands and all-purpose rings. Whether you’re an athlete, ... silicone rings designed just for you. , From the rock face to the auto ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)... BOSTON , June 16, 2017  Exactly 50 years ... kicked off what later became known as the San Francisco ... www.northernlight.com ) is unveiling two radical innovations in strategic market ... summer.  This announcement marks the beginning of Northern Light,s "Summer ... ...
(Date:6/14/2017)... N.C. , June 14, 2017  In 2016, ... Creative Startups pitch competition and came away ... reality platform is described by Forbes as "entering the ... American Medical Association as teaching "empathy to medical professionals ... the startup was recently named a finalist for the ...
(Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company (NYSE: ... three Phase 3 studies of galcanezumab, an investigational treatment ... late-breaking data on several key secondary endpoints for galcanezumab ... from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be ... scientific meeting in Boston . ...
Breaking Medicine Technology: